Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Stx17 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX17 mRNA | CTD | PMID:22079256 | Stx17 | Rat | 1,2-dichloroethane | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of STX17 mRNA | CTD | PMID:28960355 | Stx17 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of STX17 mRNA | CTD | PMID:22206623 | Stx17 | Rat | 1,3-dinitrobenzene | affects expression | EXP | | 6480464 | 3-dinitrobenzene affects the expression of STX17 mRNA | CTD | PMID:24140754 | Stx17 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of STX17 mRNA | CTD | PMID:17942748 | Stx17 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Stx17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STX17 mRNA | CTD | PMID:17942748 | Stx17 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Stx17 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of STX17 mRNA | CTD | PMID:17555576 | Stx17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Stx17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STX17 mRNA | CTD | PMID:17942748 | Stx17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Stx17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of STX17 mRNA | CTD | PMID:21570461 | Stx17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STX17 mRNA | CTD | PMID:19933214 | Stx17 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of STX17 mRNA | CTD | PMID:21346803 | Stx17 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of STX17 mRNA | CTD | PMID:28973697 | Stx17 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of STX17 mRNA | CTD | PMID:31881176 | Stx17 | Rat | aflatoxin B1 | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of STX17 mRNA | CTD | PMID:19770486 | Stx17 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of STX17 mRNA | CTD | PMID:16483693 | Stx17 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of STX17 mRNA | CTD | PMID:30779732 | Stx17 | Rat | antirheumatic drug | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of STX17 mRNA | CTD | PMID:24449571 | Stx17 | Rat | aristolochic acid A | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of STX17 mRNA | CTD | PMID:33212167 | Stx17 | Rat | benzo[b]fluoranthene | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of STX17 mRNA | CTD | PMID:26377693 | Stx17 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of STX17 mRNA | CTD | PMID:25181051 | Stx17 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of STX17 gene | CTD | PMID:28505145 | Stx17 | Rat | cadmium atom | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STX17 more ... | CTD | PMID:35301059 | Stx17 | Rat | cadmium dichloride | increases expression | ISO | STX17 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of STX17 mRNA | CTD | PMID:26472689 | Stx17 | Rat | cadmium dichloride | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STX17 more ... | CTD | PMID:35301059 | Stx17 | Rat | caffeine | decreases phosphorylation | ISO | STX17 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of STX17 protein | CTD | PMID:35688186 | Stx17 | Rat | coumestrol | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of STX17 mRNA | CTD | PMID:19167446 | Stx17 | Rat | cyclosporin A | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of STX17 mRNA | CTD | PMID:19770486 | Stx17 | Rat | Dibutyl phosphate | affects expression | ISO | STX17 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of STX17 mRNA | CTD | PMID:37042841 | Stx17 | Rat | dibutyl phthalate | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of STX17 mRNA | CTD | PMID:21266533 | Stx17 | Rat | dorsomorphin | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Stx17 | Rat | doxorubicin | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of STX17 mRNA | CTD | PMID:29803840 | Stx17 | Rat | entinostat | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | entinostat results in decreased expression of STX17 mRNA | CTD | PMID:26272509 | Stx17 | Rat | entinostat | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Stx17 | Rat | enzyme inhibitor | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Stx17 | Rat | folic acid | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of STX17 mRNA | CTD | PMID:25629700 | Stx17 | Rat | FR900359 | decreases phosphorylation | ISO | STX17 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of STX17 protein | CTD | PMID:37730182 | Stx17 | Rat | lanthanum trichloride | increases expression | EXP | | 6480464 | lanthanum chloride results in increased expression of STX17 protein | CTD | PMID:35090998 | Stx17 | Rat | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of STX17 mRNA; Methamphetamine results in decreased expression of STX17 more ... | CTD | PMID:34374793 | Stx17 | Rat | methamphetamine | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | Methamphetamine results in decreased expression of STX17 mRNA; Methamphetamine results in decreased expression of STX17 more ... | CTD | PMID:35643125 | Stx17 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | STX17 protein inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]; STX17 protein more ... | CTD | PMID:34374793 | Stx17 | Rat | methylmercury chloride | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of STX17 mRNA | CTD | PMID:28001369 | Stx17 | Rat | okadaic acid | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of STX17 mRNA | CTD | PMID:38832940 | Stx17 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of STX17 mRNA | CTD | PMID:37995155 | Stx17 | Rat | pirinixic acid | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of STX17 mRNA | CTD | PMID:18301758 | Stx17 | Rat | potassium chromate | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX17 mRNA | CTD | PMID:22079256 | Stx17 | Rat | potassium chromate | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of STX17 mRNA | CTD | PMID:22079256 | Stx17 | Rat | resveratrol | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of STX17 mRNA | CTD | PMID:23557933 | Stx17 | Rat | SB 431542 | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Stx17 | Rat | selenomethionine | affects expression | ISO | STX17 (Homo sapiens) | 6480464 | Selenomethionine affects the expression of STX17 mRNA | CTD | PMID:17222674 | Stx17 | Rat | silicon dioxide | decreases expression | ISO | Stx17 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of STX17 mRNA | CTD | PMID:19073995 | Stx17 | Rat | sodium arsenite | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of STX17 mRNA | CTD | PMID:28595984 | Stx17 | Rat | sunitinib | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of STX17 mRNA | CTD | PMID:31533062 | Stx17 | Rat | tamoxifen | affects expression | ISO | Stx17 (Mus musculus) | 6480464 | Tamoxifen affects the expression of STX17 mRNA | CTD | PMID:17555576 | Stx17 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of STX17 mRNA | CTD | PMID:31150632 | Stx17 | Rat | tetraphene | increases expression | ISO | Stx17 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of STX17 mRNA | CTD | PMID:26377693 | Stx17 | Rat | triphenyl phosphate | affects expression | ISO | STX17 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of STX17 mRNA | CTD | PMID:37042841 | Stx17 | Rat | valproic acid | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of STX17 mRNA | CTD | PMID:23179753 | Stx17 | Rat | valproic acid | increases expression | ISO | STX17 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of STX17 mRNA | CTD | PMID:26272509|PMID:28001369 | Stx17 | Rat | valproic acid | multiple interactions | ISO | STX17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Stx17 | Rat | vitamin E | decreases expression | ISO | STX17 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of STX17 mRNA | CTD | PMID:19244175 | Stx17 | Rat | zoledronic acid | increases expression | ISO | STX17 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of STX17 mRNA | CTD | PMID:20977926 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















